What is Clarapath?
Founded in 2014 and headquartered in Hawthorne, New York, Clarapath is dedicated to catalyzing change within pathology laboratories through advanced robotics. The company aims to modernize workflows, enhance efficiency, and improve diagnostic accuracy in a critical area of healthcare. By developing cutting-edge technological solutions, Clarapath positions itself as a key player in the medical technology sector, addressing the evolving needs of diagnostic services.
How much funding has Clarapath raised?
Clarapath has raised a total of $68M across 2 funding rounds:
Series B
$32M
Series B
$36M
Series B (2021): $32M with participation from East Post Road Ventures, P5 Health Ventures, and Epiphron Capital Group
Series B (2024): $36M led by Mayo Clinic and CU Healthcare Innovation Fund
Key Investors in Clarapath
Mayo Clinic
Mayo Clinic, a globally recognized nonprofit healthcare organization, is known for its integrated clinical practice, education, and medical research. Its involvement suggests a strategic interest in advancing healthcare innovation and patient care through technology.
CU Healthcare Innovation Fund
CU Healthcare Innovation Fund, affiliated with the University of Colorado Anschutz Medical Campus, specializes in advancing healthcare innovation. Their investment indicates a focus on early-stage medical technologies with strong potential for clinical impact and commercialization.
East Post Road Ventures
East Post Road Ventures is a venture capital firm focused on pre-seed, seed, and early-stage investments in healthcare ideas and medical devices, aiming to commercialize innovative solutions that improve care delivery.
What's next for Clarapath?
The substantial enterprise-level funding, particularly the recent major strategic investment, signals Clarapath's readiness for accelerated scaling and market penetration. This capital infusion is likely to fuel further research and development, expansion of manufacturing capabilities, and broader commercialization efforts. The company's focus on innovation in pathology robotics suggests a strategic push to capture a larger market share and solidify its position as a leader in medical laboratory automation, potentially leading to new partnerships and enhanced service offerings.
See full Clarapath company page
